Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure.
C
C
Torp-Pedersen
M
M
Moller
L
L
Kober
A J
AJ
Camm
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006333:Heart Failure / Q000150:complications* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D010627:Phenethylamines / Q000627:therapeutic use*; D026902:Potassium Channel Blockers; D013449:Sulfonamides / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D010627:Phenethylamines; D026902:Potassium Channel Blockers; D013449:Sulfonamides; C063533:dofetilide